[Treatment of stomach ulcer and of Zollinger-Ellison syndrome with cimetidine]
- PMID: 735716
[Treatment of stomach ulcer and of Zollinger-Ellison syndrome with cimetidine]
Abstract
The treatment of gastric ulcer by the H2-receptor-antagonist Cimetidine results in an ulcer healing rate of 60 to 80% during a 4 to 6 weeks therapy cure. In most studies Cimetidine is superior to placebo or equipotent to a high dose antacid regimen, the latter being accepted to be of beneficial effect on ulcer healing. In the Zollinger-Ellison-syndrome Cimetidine inhibits largely gastric acid hypersecretion and represents for the first time a true alternative to total gastrectomy.
Similar articles
-
Drug therapy: Cimetidine.N Engl J Med. 1978 Nov 2;299(18):992-6. doi: 10.1056/NEJM197811022991806. N Engl J Med. 1978. PMID: 357977 Review. No abstract available.
-
Cimetidine and placebo in the treatment of benign gastric ulcer: a multicenter double blind study.Gastroenterology. 1978 Feb;74(2 Pt 2):410-5. Gastroenterology. 1978. PMID: 340331 Clinical Trial.
-
Zollinger-Ellison syndrome unresponsive to cimetidine.Am J Gastroenterol. 1979 Aug;72(2):168-70. Am J Gastroenterol. 1979. PMID: 474557
-
[Treatment of Zollinger Ellison's syndrome with cimetidine (author's transl)].Rev Med Chil. 1978 Jun;106(6):450-2. Rev Med Chil. 1978. PMID: 715318 Spanish. No abstract available.
-
H2-receptor antagonists in perspective.Mayo Clin Proc. 1978 Mar;53(3):184-90. Mayo Clin Proc. 1978. PMID: 24155 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources